吉利德高管透露:Lenacapavir去年底首次在撒哈拉以南非洲国家完成交付 与美国上市同年实现

美股速递
Jan 13

吉利德科学公司高管近日披露,其创新HIV治疗药物Lenacapavir于去年年底首次在撒哈拉以南非洲地区完成交付。这一里程碑事件的发生时间,恰逢该药物同期在美国市场正式推出之年。此次突破性进展标志着抗艾滋病药物可及性的重要跨越,凸显了创新医疗方案向全球高危区域同步推进的战略意义。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10